2024-08-09T15:33:35 n5783

Linked-evidence model of qualitative G6PD testing

Viewed: 217

This model compares the number of severe haemolysis events and Plasmodium vivax recurrences within 6 months of treatment for three scenarios; low-dose primaquine (PQ) provided to all patients (baseline), low-dose PQ provided to patients who test G6PD-normal using a qualitative G6PD test and intermediate-dose PQ provided to patients to test G6PD-normal on a qualitative G6PD test. In the G6PD testing scenarios, patients who test G6PD-deficient are provided 8-week PQ.

The model is created in the TreeAge Pro Healthcare (2024) software and represents a theoretical population of 10,000 male P. vivax patients with a 1% prevelance of G6PD-deficiency.

Research areas

Mathematical modelling
Mosquito-borne disease
G6PD test
Infectious diseases
Public health
Biostatistics
Plasmodium vivax
Malaria
Diagnostics
Radical cure
G6PD deficiency

Cite this collection

Gatton, Michelle; (2024): Linked-evidence model of qualitative G6PD testing. Queensland University of Technology. (Software) https://doi.org/10.25912/RDF_1723181452844

Related information

Centre for Immunology and Infection Control, QUT https://research.qut.edu.au/ciic/

Licence


Creative Commons Attribution 4.0 (CC-BY)
http://creativecommons.org/licenses/by/4.0/

Copyright

© Queensland University of Technology, 2024.

Data file types

File format is .trex and requires the TreeAge Pro Healthcare.

Dates of development

From 2023-10-10 to 2024-02-06

Contacts

Other

Date record created:
2024-06-22T10:51:22
Date record modified:
2024-08-09T15:33:35
Record status:
Published - Open Access